{"id":"https://openalex.org/W2589033892","doi":"https://doi.org/10.3928/23258160-20170130-02","title":"An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications","display_name":"An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W2589033892","doi":"https://doi.org/10.3928/23258160-20170130-02","mag":"2589033892","pmid":"https://pubmed.ncbi.nlm.nih.gov/28195611"},"language":"en","primary_location":{"id":"doi:10.3928/23258160-20170130-02","doi":"https://doi.org/10.3928/23258160-20170130-02","is_oa":true,"landing_page_url":"https://doi.org/10.3928/23258160-20170130-02","pdf_url":"https://journals.healio.com/doi/epdf/10.3928/23258160-20170130-02","source":{"id":"https://openalex.org/S4210179932","display_name":"Ophthalmic surgery, lasers & imaging retina","issn_l":"1542-8877","issn":["1542-8877","1938-2375","2325-8160","2325-8179"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800624","host_organization_name":"Slack Incorporated (United States)","host_organization_lineage":["https://openalex.org/P4320800624"],"host_organization_lineage_names":["Slack Incorporated (United States)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic Surgery, Lasers and Imaging Retina","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2589033892"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.healio.com/doi/epdf/10.3928/23258160-20170130-02","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040917298","display_name":"Evan N. Dunn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Evan N. Dunn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004500397","display_name":"Veeral S. Sheth","orcid":"https://orcid.org/0000-0002-7467-9947","observed_orcids":["https://orcid.org/0000-0002-7467-9947"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veeral S. Sheth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030673049","display_name":"Seenu M. Hariprasad","orcid":"https://orcid.org/0000-0003-0985-9551","observed_orcids":["https://orcid.org/0000-0003-0985-9551"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seenu M. Hariprasad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.6974,"has_fulltext":true,"cited_by_count":74,"citation_normalized_percentile":{"value":0.98135697,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"48","issue":"2","first_page":"100","last_page":"104"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.8840000033378601},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/vitreoretinal-disorders","display_name":"vitreoretinal disease","score":0.7590000033378601},{"id":"https://openalex.org/keywords/clinical-trial-failure","display_name":"clinical trial failure","score":0.6639999747276306},{"id":"https://openalex.org/keywords/multi-target-therapy","display_name":"multi-target therapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.8989999890327454}],"concepts":[{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.5925848484039307},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4190137982368469},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32109421491622925},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.280229389667511},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.11940303444862366},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07272428274154663}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010982","descriptor_name":"Platelet-Derived Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3928/23258160-20170130-02","doi":"https://doi.org/10.3928/23258160-20170130-02","is_oa":true,"landing_page_url":"https://doi.org/10.3928/23258160-20170130-02","pdf_url":"https://journals.healio.com/doi/epdf/10.3928/23258160-20170130-02","source":{"id":"https://openalex.org/S4210179932","display_name":"Ophthalmic surgery, lasers & imaging retina","issn_l":"1542-8877","issn":["1542-8877","1938-2375","2325-8160","2325-8179"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800624","host_organization_name":"Slack Incorporated (United States)","host_organization_lineage":["https://openalex.org/P4320800624"],"host_organization_lineage_names":["Slack Incorporated (United States)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic Surgery, Lasers and Imaging Retina","raw_type":"journal-article"},{"id":"pmid:28195611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28195611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic surgery, lasers & imaging retina","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/10760849","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/An_Overview_of_the_Fovista_and_Rinucumab_Trials_and_the_Fate_of_Anti-PDGF_Medications/10760849","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3928/23258160-20170130-02","doi":"https://doi.org/10.3928/23258160-20170130-02","is_oa":true,"landing_page_url":"https://doi.org/10.3928/23258160-20170130-02","pdf_url":"https://journals.healio.com/doi/epdf/10.3928/23258160-20170130-02","source":{"id":"https://openalex.org/S4210179932","display_name":"Ophthalmic surgery, lasers & imaging retina","issn_l":"1542-8877","issn":["1542-8877","1938-2375","2325-8160","2325-8179"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800624","host_organization_name":"Slack Incorporated (United States)","host_organization_lineage":["https://openalex.org/P4320800624"],"host_organization_lineage_names":["Slack Incorporated (United States)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic Surgery, Lasers and Imaging Retina","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2589033892.pdf","grobid_xml":"https://content.openalex.org/works/W2589033892.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2004117352","https://openalex.org/W2011393181","https://openalex.org/W2043146189","https://openalex.org/W2085712747","https://openalex.org/W2107457439","https://openalex.org/W2124415048","https://openalex.org/W2172453889","https://openalex.org/W2433379345","https://openalex.org/W2543150770","https://openalex.org/W4250031098","https://openalex.org/W4256101427"],"related_works":["https://openalex.org/W2678637432","https://openalex.org/W1677847122","https://openalex.org/W2288429410","https://openalex.org/W2593646126","https://openalex.org/W1912379587","https://openalex.org/W2543150770","https://openalex.org/W2031079052","https://openalex.org/W3163088292","https://openalex.org/W4406665416","https://openalex.org/W883628042"],"abstract_inverted_index":{"The":[0,33],"vitreoretinal":[1,129],"community":[2,142],"will":[3,86,172],"remember":[4],"2016":[5],"as":[6,95,97,103],"the":[7,19,41,73,80,116,123,126,151],"year":[8],"that":[9,153],"unfavorable":[10],"anti\u2013platelet-derived":[11],"growth":[12,49],"factor":[13,50],"(anti-PDGF)":[14],"clinical":[15,75,133],"trial":[16,134],"results":[17,135],"ended":[18],"development":[20,155],"of":[21,35,100,119,128],"Fovista":[22],"(pegpleranib;":[23],"Ophthotech,":[24],"New":[25],"York,":[26],"NY)":[27],"and":[28,56,62,71,105,169],"Rinucumab":[29],"(Regeneron,":[30],"Tarrytown,":[31],"NY).":[32],"failure":[34],"these":[36],"trials":[37,76],"reaffirmed":[38],"how":[39,114],"important":[40],"innovations":[42],"made":[43],"in":[44],"2006":[45],"with":[46,69,79],"anti-vascular":[47],"endothelial":[48],"(anti-VEGF)":[51],"were":[52,67],"to":[53,92,112,140,163],"our":[54,57,93,141,144,177],"field":[55],"patients.\\n\\nEvan":[58],"N.":[59],"Dunn,":[60],"MD,":[61,66],"Veeral":[63],"S.":[64],"Sheth,":[65],"tasked":[68],"analyzing":[70],"dissecting":[72],"anti-PDGF":[74],"\u2014":[77],"beginning":[78],"basic":[81],"science":[82],"behind":[83],"anti-PDGF.":[84],"They":[85],"also":[87],"review":[88],"novel,":[89],"multitarget":[90],"approaches":[91,162],"diseases,":[94],"well":[96],"unique":[98],"routes":[99],"delivery":[101],"such":[102],"topical":[104],"suprachoroidal":[106],"administration.\\n\\nReading":[107],"this":[108],"article":[109],"leads":[110],"one":[111],"appreciate":[113],"high":[115],"anti-VEGF":[117],"class":[118],"molecules":[120],"has":[121],"set":[122],"bar":[124],"for":[125],"treatment":[127],"disease.":[130],"Although":[131],"recent":[132],"have":[136],"been":[137],"a":[138],"disappointment":[139],"(and":[143],"patients),":[145],"we":[146],"should":[147],"be":[148,173],"reassured":[149],"by":[150,176],"fact":[152],"many":[154],"programs":[156],"are":[157],"strongly":[158],"underway":[159],"investigating":[160],"novel":[161],"treat":[164],"back-of-the-eye":[165],"disorders.":[166],"Drs.":[167],"Dunn":[168],"Sheth's":[170],"insights":[171],"highly":[174],"valued":[175],"community.":[178]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2589033892","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-02-24T00:00:00"}
